Company: JUPGF
Filing Date: 2025-05-02
Form Type: DRS
Source: 0001641172-25-008279
Chunk: 3

Company: ATLAS CRITICAL MINERALS Corp
Filing Date: 2025-05-02
Form: DRS
Chunk 3
---
         
 commissions(2)                     |     | $            |     | $     |
| Proceeds to us, before expenses(3) |     | $            |     | $     |

| (1) | Represents                                                                                                                             
 the estimated public offering price. The actual offering price will be determined by negotiations between us and the underwriters      
 and may not be indicative of prices of the actual offering price                                                                       |
| (2) | We                                                                                                                                     
 have agreed to pay the underwriters underwriting discounts and commissions equal to (i) 7.0% of the aggregate gross proceeds in this   
 Offering from the sale of securities to certain investors and (ii) 3.0% of the aggregate gross proceeds in this Offering               
 from the sale of securities to certain other investors.                                                                                |
| (3) | Does                                                                                                                                   
 not include a non-accountable expense allowance of up to $20,000 payable to the underwriters, or the reimbursement of certain expenses 
 of the underwriters, including legal fees of up to $200,000. We have also agreed to issue the representative of the underwriters       
 a warrant to purchase a number of shares of common stock equal to 6.0% of the total number of shares of common stock sold in this      
 Offering at an exercise price equal to 115% of the initial public offering price of the shares of common stock sold in this Offering.  
 For additional information regarding underwriters’ compensation, see “Underwriting” beginning on page 105. The                         
 registration statement of which this prospectus is a part also covers the shares of common stock issuable upon the exercise of the     
 underwriter warrants.                                                                                                                  |

We have granted to the underwriters a 45-day option to purchase from us up to an additional [●] shares, representing 15% of the shares of common stock sold in the offering, solely to cover over-allotments, if any, at the public offering price per share, less the underwriting discounts.

The underwriters expect to deliver our common stock to purchasers in this offering on or about , 2025.

Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the accuracy or adequacy of this prospectus. Any representation to the contrary is a criminal offense

| A.G.P. | Bradesco BBI |

<div align='center'>The date of this prospectus is , 2025.</div>

<div align='center'>TABLE OF CONTENTS</div>